PT - JOURNAL ARTICLE AU - Einat Even-Sapir AU - Gideon Flusser AU - Hedva Lerman AU - Gennady Lievshitz AU - Ur Metser TI - SPECT/Multislice Low-Dose CT: A Clinically Relevant Constituent in the Imaging Algorithm of Nononcologic Patients Referred for Bone Scintigraphy DP - 2007 Feb 01 TA - Journal of Nuclear Medicine PG - 319--324 VI - 48 IP - 2 4099 - http://jnm.snmjournals.org/content/48/2/319.short 4100 - http://jnm.snmjournals.org/content/48/2/319.full SO - J Nucl Med2007 Feb 01; 48 AB - The purpose of this prospective study was to assess the role of SPECT/multislice low-dose (Msl) CT as a constituent in the imaging algorithm of nononcologic patients referred for 99mTc-methylene diphosphonate bone scintigraphy (BS). Methods: SPECT/CT was performed using a novel hybrid system, which incorporates a γ-camera and a multislice low-dose CT, on 76 consecutive nononcologic patients with nonspecific scintigraphic findings, which required further correlation with morphologic data. Results: SPECT/MslCT was of added clinical value in 89% of the patients. Characterizing scintigraphic lesions by their morphologic appearance, SPECT/MslCT reached a final diagnosis in 49 of 85 (58%) nonspecific scintigraphic bone lesions found in 59% (45/76) of patients, obviating the need to perform additional imaging. In another 30% of patients (23/76), SPECT/MslCT data optimized the patients' imaging algorithm as the performance of a full-dose CT, MRI, or labeled-leukocyte scintigraphy as the next imaging was based on its findings combined with the patient's clinical presentation. Conclusion: SPECT/MslCT is a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for BS.